Parametric Portfolio Associates’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $887K | Sell |
27,557
-4,887
| -15% | -$157K | ﹤0.01% | 2833 |
|
|
2021
Q4 | $1.45M | Sell |
32,444
-554
| -2% | -$24.7K | ﹤0.01% | 2626 |
|
|
2021
Q3 | $1.67M | Sell |
32,998
-31,211
| -49% | -$1.57M | ﹤0.01% | 2534 |
|
|
2021
Q2 | $5.04M | Buy |
64,209
+20,390
| +47% | +$1.6M | ﹤0.01% | 1848 |
|
|
2021
Q1 | $2.5M | Sell |
43,819
-2,596
| -6% | -$148K | ﹤0.01% | 2630 |
|
|
2020
Q4 | $3.89M | Sell |
46,415
-10,002
| -18% | -$838K | ﹤0.01% | 2236 |
|
|
2020
Q3 | $2.02M | Buy |
56,417
+40,027
| +244% | +$1.43M | ﹤0.01% | 2504 |
|
|
2020
Q2 | $396K | Buy |
16,390
+4,514
| +38% | +$109K | ﹤0.01% | 3367 |
|
|
2020
Q1 | $208K | Sell |
11,876
-46
| -0.4% | -$806 | ﹤0.01% | 3535 |
|
|
2019
Q4 | $208K | Sell |
11,922
-344
| -3% | -$6K | ﹤0.01% | 3731 |
|
|
2019
Q3 | $188K | Buy |
+12,266
| New | +$188K | ﹤0.01% | 3729 |
|